Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Wellness.
RELATED STOCKHEAD STORIES
News
Trading Places: Rinehart makes play for Warrego Energy, Whitehaven gets new substantial shareholder
News
ASX Small Caps Lunch Wrap: Who else wants to bust up monopolies this morning?
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Weed Week: Will the US Senate pass the MORE act, and Swiss cannabis wellness spas are a thing
Health & Biotech
California just passed a bill to legalise hemp – and there are ASX cannabis stocks that could benefit
Health & Biotech
In Canada, cannabis is as big as autos… and these ASX stocks are in for the ride
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
Health & Biotech
ScoPo’s Powerplays: ‘Go long equities’ as Nanosonics, Antisense, Volpara to benefit from V-shaped recovery
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
News
Last Orders: COVID outbreaks weigh on the ASX again
News
Last Orders: ASX finishes up despite investors jumping off Airtasker float
Health & Biotech
Here’s why cannabis M&A activity is on the rise and only just getting started in Australia
Health & Biotech
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board
News
Rise and Shine: What you need to know before the ASX opens
News
Trading Places: Which ASX shares have institutional investors been buying over January?
News
Closing Bell: Today’s biggest small cap movers on the ASX
News